Database Query Results : , , FLT3

FLT3, fms-related tyrosine kinase 3: Click to Expand ⟱
Source: CGL-Driver Genes
Type: Oncogene
FMS-related tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that plays a significant role in hematopoiesis and is primarily expressed in hematopoietic stem cells and progenitor cells. It is particularly important in the context of acute myeloid leukemia (AML), where mutations in the FLT3 gene are among the most common genetic alterations.
FLT3 inhibitors, such as midostaurin, gilteritinib, and quizartinib, have been developed to specifically target and inhibit the activity of the mutated FLT3 receptor.


Scientific Papers found: Click to Expand⟱
3377- QC,    Quercetin inhibits a large panel of kinases implicated in cancer cell biology
PDGF↓, FLT3↓, JAK3↓, MET↓, RET↓, FGFR2↓, other↓,
2212- SK,    Shikonin Exerts an Antileukemia Effect against FLT3-ITD Mutated Acute Myeloid Leukemia Cells via Targeting FLT3 and Its Downstream Pathways
- in-vitro, AML, NA
FLT3↓, NF-kB↓, miR-155↓, Diff↑, TumCG↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Kinase & Signal Transduction

RET↓, 1,  

Transcription & Epigenetics

other↓, 1,  

Proliferation, Differentiation & Cell State

Diff↑, 1,   FGFR2↓, 1,   FLT3↓, 2,   TumCG↓, 1,  

Migration

MET↓, 1,   miR-155↓, 1,   PDGF↓, 1,  

Immune & Inflammatory Signaling

JAK3↓, 1,   NF-kB↓, 1,  
Total Targets: 11

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: FLT3, fms-related tyrosine kinase 3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:118  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page